19:I[66739,["/_next/static/chunks/0.3dg.jzl0xwf.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0qxr~fpya2kw0.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/12wfgjmhh21qu.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/028~snn2srcd-.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/079qbl7l5rd72.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0hi8o2xq05aig.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA"],"default"] 1b:I[38632,["/_next/static/chunks/0qqtp3r0h7kah.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0iukvycbd42rl.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA"],"IconMark"] 1a:T498,

On this episode of Rapid Response, Ro CEO Zach Reitano joins the show to talk about what happens when a breakout drug becomes a full-blown market force. Since first appearing at the height of the Ozempic-Wegovy-Zepbound boom, Reitano has helped scale Ro into a leading provider of branded GLP-1s — grabbing headlines with a Super Bowl ad featuring Serena Williams and landing a major partnership with Novo Nordisk for the new pill version of Wegovy. He also takes on the tougher questions: the long-term health unknowns, the cultural backlash to “Ozempic face,” and what this wave of disruption could mean not just for pharma, but for the future of healthcare.

Visit the Rapid Response website here: https://www.rapidresponseshow.com/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The GLP-1 economy is here, with Ro’s Zach Reitano

Rapid Response

The GLP-1 economy is here, with Ro’s Zach Reitano